Puma Biotechnology Inc (PBYI)

Cost of Revenue

$12.48M

Quarterly · Period ending: · USD

PBYI logo

PBYI Cost of Revenue

Latest reported$12.48M
PBYI Quarterly Cost of Revenue ($0.00 → $12.48M)
High-resolution chart · PNG

PBYI cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Puma Biotechnology Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
12,475,000
10,424,000
23,127,000
12,173,000
12,301,000
10,556,000
13,921,000
29,097,000
10,658,000
10,728,000
24,323,000
13,284,000
11,857,000
13,218,000
16,836,000
12,495,000
14,918,000
10,844,000
11,895,000
10,279,000
11,969,000
29,557,000
10,940,000
9,943,000
9,415,000
9,076,000
10,142,000
9,400,000
9,317,000
8,000,000
10,300,000
9,000,000
8,831,000
6,383,000
4,100,000
1,526,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.